313 related articles for article (PubMed ID: 22158945)
1. S100A7 enhances mammary tumorigenesis through upregulation of inflammatory pathways.
Nasser MW; Qamri Z; Deol YS; Ravi J; Powell CA; Trikha P; Schwendener RA; Bai XF; Shilo K; Zou X; Leone G; Wolf R; Yuspa SH; Ganju RK
Cancer Res; 2012 Feb; 72(3):604-15. PubMed ID: 22158945
[TBL] [Abstract][Full Text] [Related]
2. Differential role of psoriasin (S100A7) in estrogen receptor α positive and negative breast cancer cells occur through actin remodeling.
Sneh A; Deol YS; Ganju A; Shilo K; Rosol TJ; Nasser MW; Ganju RK
Breast Cancer Res Treat; 2013 Apr; 138(3):727-39. PubMed ID: 23535840
[TBL] [Abstract][Full Text] [Related]
3. Tumor-suppressive effects of psoriasin (S100A7) are mediated through the β-catenin/T cell factor 4 protein pathway in estrogen receptor-positive breast cancer cells.
Deol YS; Nasser MW; Yu L; Zou X; Ganju RK
J Biol Chem; 2011 Dec; 286(52):44845-54. PubMed ID: 22016394
[TBL] [Abstract][Full Text] [Related]
4. miR-29b defines the pro-/anti-proliferative effects of S100A7 in breast cancer.
Zhao H; Wilkie T; Deol Y; Sneh A; Ganju A; Basree M; Nasser MW; Ganju RK
Mol Cancer; 2015 Jan; 14():11. PubMed ID: 25622979
[TBL] [Abstract][Full Text] [Related]
5. Interaction with adipocyte stromal cells induces breast cancer malignancy via S100A7 upregulation in breast cancer microenvironment.
Sakurai M; Miki Y; Takagi K; Suzuki T; Ishida T; Ohuchi N; Sasano H
Breast Cancer Res; 2017 Jun; 19(1):70. PubMed ID: 28629450
[TBL] [Abstract][Full Text] [Related]
6. S100A7 enhances invasion of human breast cancer MDA-MB-468 cells through activation of nuclear factor-κB signaling.
Liu H; Wang L; Wang X; Cao Z; Yang Q; Zhang K
World J Surg Oncol; 2013 Apr; 11():93. PubMed ID: 23618129
[TBL] [Abstract][Full Text] [Related]
7. Gene from a psoriasis susceptibility locus primes the skin for inflammation.
Wolf R; Mascia F; Dharamsi A; Howard OM; Cataisson C; Bliskovski V; Winston J; Feigenbaum L; Lichti U; Ruzicka T; Chavakis T; Yuspa SH
Sci Transl Med; 2010 Dec; 2(61):61ra90. PubMed ID: 21148126
[TBL] [Abstract][Full Text] [Related]
8. RAGE mediates S100A7-induced breast cancer growth and metastasis by modulating the tumor microenvironment.
Nasser MW; Wani NA; Ahirwar DK; Powell CA; Ravi J; Elbaz M; Zhao H; Padilla L; Zhang X; Shilo K; Ostrowski M; Shapiro C; Carson WE; Ganju RK
Cancer Res; 2015 Mar; 75(6):974-85. PubMed ID: 25572331
[TBL] [Abstract][Full Text] [Related]
9. cPLA2 blockade attenuates S100A7-mediated breast tumorigenicity by inhibiting the immunosuppressive tumor microenvironment.
Mishra S; Charan M; Shukla RK; Agarwal P; Misri S; Verma AK; Ahirwar DK; Siddiqui J; Kaul K; Sahu N; Vyas K; Garg AA; Khan A; Miles WO; Song JW; Bhutani N; Ganju RK
J Exp Clin Cancer Res; 2022 Feb; 41(1):54. PubMed ID: 35135586
[TBL] [Abstract][Full Text] [Related]
10. Cyclin A1 modulates the expression of vascular endothelial growth factor and promotes hormone-dependent growth and angiogenesis of breast cancer.
Syed Khaja AS; Dizeyi N; Kopparapu PK; Anagnostaki L; Härkönen P; Persson JL
PLoS One; 2013; 8(8):e72210. PubMed ID: 23991063
[TBL] [Abstract][Full Text] [Related]
11. Psoriasin (S100A7) increases the expression of ROS and VEGF and acts through RAGE to promote endothelial cell proliferation.
Shubbar E; Vegfors J; Carlström M; Petersson S; Enerbäck C
Breast Cancer Res Treat; 2012 Jul; 134(1):71-80. PubMed ID: 22189627
[TBL] [Abstract][Full Text] [Related]
12. Chemotactic activity of S100A7 (Psoriasin) is mediated by the receptor for advanced glycation end products and potentiates inflammation with highly homologous but functionally distinct S100A15.
Wolf R; Howard OM; Dong HF; Voscopoulos C; Boeshans K; Winston J; Divi R; Gunsior M; Goldsmith P; Ahvazi B; Chavakis T; Oppenheim JJ; Yuspa SH
J Immunol; 2008 Jul; 181(2):1499-506. PubMed ID: 18606705
[TBL] [Abstract][Full Text] [Related]
13. Expression analysis of the mouse S100A7/psoriasin gene in skin inflammation and mammary tumorigenesis.
Webb M; Emberley ED; Lizardo M; Alowami S; Qing G; Alfia'ar A; Snell-Curtis LJ; Niu Y; Civetta A; Myal Y; Shiu R; Murphy LC; Watson PH
BMC Cancer; 2005 Feb; 5():17. PubMed ID: 15717926
[TBL] [Abstract][Full Text] [Related]
14. Estrogen receptor-beta regulates psoriasin (S100A7) in human breast cancer.
Skliris GP; Lewis A; Emberley E; Peng B; Weebadda WK; Kemp A; Davie JR; Shiu RP; Watson PH; Murphy LC
Breast Cancer Res Treat; 2007 Jul; 104(1):75-85. PubMed ID: 17009105
[TBL] [Abstract][Full Text] [Related]
15. Loss of ICAM-1 signaling induces psoriasin (S100A7) and MUC1 in mammary epithelial cells.
Petersson S; Shubbar E; Yhr M; Kovacs A; Enerbäck C
Breast Cancer Res Treat; 2011 Jan; 125(1):13-25. PubMed ID: 20217214
[TBL] [Abstract][Full Text] [Related]
16. Suppression of heat shock protein 27 induces long-term dormancy in human breast cancer.
Straume O; Shimamura T; Lampa MJ; Carretero J; Øyan AM; Jia D; Borgman CL; Soucheray M; Downing SR; Short SM; Kang SY; Wang S; Chen L; Collett K; Bachmann I; Wong KK; Shapiro GI; Kalland KH; Folkman J; Watnick RS; Akslen LA; Naumov GN
Proc Natl Acad Sci U S A; 2012 May; 109(22):8699-704. PubMed ID: 22589302
[TBL] [Abstract][Full Text] [Related]
17. S100A7 (psoriasin) is induced by the proinflammatory cytokines oncostatin-M and interleukin-6 in human breast cancer.
West NR; Watson PH
Oncogene; 2010 Apr; 29(14):2083-92. PubMed ID: 20101226
[TBL] [Abstract][Full Text] [Related]
18. Fibroblast growth factor receptor signaling dramatically accelerates tumorigenesis and enhances oncoprotein translation in the mouse mammary tumor virus-Wnt-1 mouse model of breast cancer.
Pond AC; Herschkowitz JI; Schwertfeger KL; Welm B; Zhang Y; York B; Cardiff RD; Hilsenbeck S; Perou CM; Creighton CJ; Lloyd RE; Rosen JM
Cancer Res; 2010 Jun; 70(12):4868-79. PubMed ID: 20501844
[TBL] [Abstract][Full Text] [Related]
19. Autophagy regulator BECN1 suppresses mammary tumorigenesis driven by WNT1 activation and following parity.
Cicchini M; Chakrabarti R; Kongara S; Price S; Nahar R; Lozy F; Zhong H; Vazquez A; Kang Y; Karantza V
Autophagy; 2014; 10(11):2036-52. PubMed ID: 25483966
[TBL] [Abstract][Full Text] [Related]
20. S100A7 as a potential diagnostic and prognostic biomarker of esophageal squamous cell carcinoma promotes M2 macrophage infiltration and angiogenesis.
Lu Z; Zheng S; Liu C; Wang X; Zhang G; Wang F; Wang S; Huang J; Mao S; Lei Y; Wang Z; Sun N; He J
Clin Transl Med; 2021 Jul; 11(7):e459. PubMed ID: 34323409
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
